Orally Administered Chemotherapy Drugs Prices Increased by 506% since 2000

In a study published in the journal JAMA Oncology, by Dr. Stacie Dusetzina, a member of the University of North Carolina’s Lineberger Comprehensive Cancer Center, examined the pricing trends for orally administered cancer products from 2000 through 2014 and found the oral cancer therapies have increased in price by an astounding 506 percent since 2000. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.